1. Home
  2. MBIO vs HSCS Comparison

MBIO vs HSCS Comparison

Compare MBIO & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBIO

Mustang Bio Inc.

HOLD

Current Price

$0.57

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

Logo Heart Test Laboratories Inc.

HSCS

Heart Test Laboratories Inc.

HOLD

Current Price

$2.39

Market Cap

6.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBIO
HSCS
Founded
2015
2007
Country
United States
United States
Employees
N/A
12
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
6.4M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
MBIO
HSCS
Price
$0.57
$2.39
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
26.7K
156.4K
Earning Date
05-13-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
98.99
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$1.63
52 Week High
$1.96
$3.93

Technical Indicators

Market Signals
Indicator
MBIO
HSCS
Relative Strength Index (RSI) 34.19 51.36
Support Level $0.53 $2.11
Resistance Level $0.82 $2.82
Average True Range (ATR) 0.04 0.23
MACD -0.01 -0.05
Stochastic Oscillator 1.32 42.57

Price Performance

Historical Comparison
MBIO
HSCS

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About HSCS Heart Test Laboratories Inc.

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

Share on Social Networks: